Cargando…
Determinants of Recovery from Severe Posterior Reversible Encephalopathy Syndrome
OBJECTIVE: Few outcome data are available about posterior reversible encephalopathy syndrome (PRES). We studied 90-day functional outcomes and their determinants in patients with severe PRES. DESIGN: 70 patients with severe PRES admitted to 24 ICUs in 2001–2010 were included in a retrospective cohor...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3443081/ https://www.ncbi.nlm.nih.gov/pubmed/23024751 http://dx.doi.org/10.1371/journal.pone.0044534 |
_version_ | 1782243516192129024 |
---|---|
author | Legriel, Stephane Schraub, Olivier Azoulay, Elie Hantson, Philippe Magalhaes, Eric Coquet, Isaline Bretonniere, Cedric Gilhodes, Olivier Anguel, Nadia Megarbane, Bruno Benayoun, Laurent Schnell, David Plantefeve, Gaetan Charpentier, Julien Argaud, Laurent Mourvillier, Bruno Galbois, Arnaud Chalumeau-Lemoine, Ludivine Rivoal, Michel Durand, François Geffroy, Arnaud Simon, Marc Stoclin, Annabelle Pallot, Jean-Louis Arbelot, Charlotte Nyunga, Martine Lesieur, Olivier Troché, Gilles Bruneel, Fabrice Cordoliani, Yves-Sébastien Bedos, Jean-Pierre Pico, Fernando |
author_facet | Legriel, Stephane Schraub, Olivier Azoulay, Elie Hantson, Philippe Magalhaes, Eric Coquet, Isaline Bretonniere, Cedric Gilhodes, Olivier Anguel, Nadia Megarbane, Bruno Benayoun, Laurent Schnell, David Plantefeve, Gaetan Charpentier, Julien Argaud, Laurent Mourvillier, Bruno Galbois, Arnaud Chalumeau-Lemoine, Ludivine Rivoal, Michel Durand, François Geffroy, Arnaud Simon, Marc Stoclin, Annabelle Pallot, Jean-Louis Arbelot, Charlotte Nyunga, Martine Lesieur, Olivier Troché, Gilles Bruneel, Fabrice Cordoliani, Yves-Sébastien Bedos, Jean-Pierre Pico, Fernando |
author_sort | Legriel, Stephane |
collection | PubMed |
description | OBJECTIVE: Few outcome data are available about posterior reversible encephalopathy syndrome (PRES). We studied 90-day functional outcomes and their determinants in patients with severe PRES. DESIGN: 70 patients with severe PRES admitted to 24 ICUs in 2001–2010 were included in a retrospective cohort study. The main outcome measure was a Glasgow Outcome Scale (GOS) of 5 (good recovery) on day 90. MAIN RESULTS: Consciousness impairment was the most common clinical sign, occurring in 66 (94%) patients. Clinical seizures occurred in 57 (81%) patients. Median mean arterial pressure was 122 (105–143) mmHg on scene. Cerebral imaging abnormalities were bilateral (93%) and predominated in the parietal (93%) and occipital (86%) white matter. Median number of brain areas involved was 4 (3–5). Imaging abnormalities resolved in 43 (88%) patients. Ischaemic and/or haemorrhagic complications occurred in 7 (14%) patients. The most common causes were drug toxicity (44%) and hypertensive encephalopathy (41%). On day 90, 11 (16%) patients had died, 26 (37%) had marked functional impairments (GOS, 2 to 4), and 33 (56%) had a good recovery (GOS, 5). Factors independently associated with GOS<5 were highest glycaemia on day 1 (OR, 1.22; 95%CI, 1.02–1.45, p = 0.03) and time to causative-factor control (OR, 3.3; 95%CI, 1.04–10.46, p = 0.04), whereas GOS = 5 was associated with toxaemia of pregnancy (preeclampsia/eclampsia) (OR, 0.06; 95%CI, 0.01–0.38, p = 0.003). CONCLUSIONS: By day 90 after admission for severe PRES, 44% of survivors had severe functional impairments. Highest glycaemia on day 1 and time to causative-factor control were strong early predictors of outcomes, suggesting areas for improvement. |
format | Online Article Text |
id | pubmed-3443081 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-34430812012-09-28 Determinants of Recovery from Severe Posterior Reversible Encephalopathy Syndrome Legriel, Stephane Schraub, Olivier Azoulay, Elie Hantson, Philippe Magalhaes, Eric Coquet, Isaline Bretonniere, Cedric Gilhodes, Olivier Anguel, Nadia Megarbane, Bruno Benayoun, Laurent Schnell, David Plantefeve, Gaetan Charpentier, Julien Argaud, Laurent Mourvillier, Bruno Galbois, Arnaud Chalumeau-Lemoine, Ludivine Rivoal, Michel Durand, François Geffroy, Arnaud Simon, Marc Stoclin, Annabelle Pallot, Jean-Louis Arbelot, Charlotte Nyunga, Martine Lesieur, Olivier Troché, Gilles Bruneel, Fabrice Cordoliani, Yves-Sébastien Bedos, Jean-Pierre Pico, Fernando PLoS One Research Article OBJECTIVE: Few outcome data are available about posterior reversible encephalopathy syndrome (PRES). We studied 90-day functional outcomes and their determinants in patients with severe PRES. DESIGN: 70 patients with severe PRES admitted to 24 ICUs in 2001–2010 were included in a retrospective cohort study. The main outcome measure was a Glasgow Outcome Scale (GOS) of 5 (good recovery) on day 90. MAIN RESULTS: Consciousness impairment was the most common clinical sign, occurring in 66 (94%) patients. Clinical seizures occurred in 57 (81%) patients. Median mean arterial pressure was 122 (105–143) mmHg on scene. Cerebral imaging abnormalities were bilateral (93%) and predominated in the parietal (93%) and occipital (86%) white matter. Median number of brain areas involved was 4 (3–5). Imaging abnormalities resolved in 43 (88%) patients. Ischaemic and/or haemorrhagic complications occurred in 7 (14%) patients. The most common causes were drug toxicity (44%) and hypertensive encephalopathy (41%). On day 90, 11 (16%) patients had died, 26 (37%) had marked functional impairments (GOS, 2 to 4), and 33 (56%) had a good recovery (GOS, 5). Factors independently associated with GOS<5 were highest glycaemia on day 1 (OR, 1.22; 95%CI, 1.02–1.45, p = 0.03) and time to causative-factor control (OR, 3.3; 95%CI, 1.04–10.46, p = 0.04), whereas GOS = 5 was associated with toxaemia of pregnancy (preeclampsia/eclampsia) (OR, 0.06; 95%CI, 0.01–0.38, p = 0.003). CONCLUSIONS: By day 90 after admission for severe PRES, 44% of survivors had severe functional impairments. Highest glycaemia on day 1 and time to causative-factor control were strong early predictors of outcomes, suggesting areas for improvement. Public Library of Science 2012-09-14 /pmc/articles/PMC3443081/ /pubmed/23024751 http://dx.doi.org/10.1371/journal.pone.0044534 Text en © 2012 Legriel et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Legriel, Stephane Schraub, Olivier Azoulay, Elie Hantson, Philippe Magalhaes, Eric Coquet, Isaline Bretonniere, Cedric Gilhodes, Olivier Anguel, Nadia Megarbane, Bruno Benayoun, Laurent Schnell, David Plantefeve, Gaetan Charpentier, Julien Argaud, Laurent Mourvillier, Bruno Galbois, Arnaud Chalumeau-Lemoine, Ludivine Rivoal, Michel Durand, François Geffroy, Arnaud Simon, Marc Stoclin, Annabelle Pallot, Jean-Louis Arbelot, Charlotte Nyunga, Martine Lesieur, Olivier Troché, Gilles Bruneel, Fabrice Cordoliani, Yves-Sébastien Bedos, Jean-Pierre Pico, Fernando Determinants of Recovery from Severe Posterior Reversible Encephalopathy Syndrome |
title | Determinants of Recovery from Severe Posterior Reversible Encephalopathy Syndrome |
title_full | Determinants of Recovery from Severe Posterior Reversible Encephalopathy Syndrome |
title_fullStr | Determinants of Recovery from Severe Posterior Reversible Encephalopathy Syndrome |
title_full_unstemmed | Determinants of Recovery from Severe Posterior Reversible Encephalopathy Syndrome |
title_short | Determinants of Recovery from Severe Posterior Reversible Encephalopathy Syndrome |
title_sort | determinants of recovery from severe posterior reversible encephalopathy syndrome |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3443081/ https://www.ncbi.nlm.nih.gov/pubmed/23024751 http://dx.doi.org/10.1371/journal.pone.0044534 |
work_keys_str_mv | AT legrielstephane determinantsofrecoveryfromsevereposteriorreversibleencephalopathysyndrome AT schraubolivier determinantsofrecoveryfromsevereposteriorreversibleencephalopathysyndrome AT azoulayelie determinantsofrecoveryfromsevereposteriorreversibleencephalopathysyndrome AT hantsonphilippe determinantsofrecoveryfromsevereposteriorreversibleencephalopathysyndrome AT magalhaeseric determinantsofrecoveryfromsevereposteriorreversibleencephalopathysyndrome AT coquetisaline determinantsofrecoveryfromsevereposteriorreversibleencephalopathysyndrome AT bretonnierecedric determinantsofrecoveryfromsevereposteriorreversibleencephalopathysyndrome AT gilhodesolivier determinantsofrecoveryfromsevereposteriorreversibleencephalopathysyndrome AT anguelnadia determinantsofrecoveryfromsevereposteriorreversibleencephalopathysyndrome AT megarbanebruno determinantsofrecoveryfromsevereposteriorreversibleencephalopathysyndrome AT benayounlaurent determinantsofrecoveryfromsevereposteriorreversibleencephalopathysyndrome AT schnelldavid determinantsofrecoveryfromsevereposteriorreversibleencephalopathysyndrome AT plantefevegaetan determinantsofrecoveryfromsevereposteriorreversibleencephalopathysyndrome AT charpentierjulien determinantsofrecoveryfromsevereposteriorreversibleencephalopathysyndrome AT argaudlaurent determinantsofrecoveryfromsevereposteriorreversibleencephalopathysyndrome AT mourvillierbruno determinantsofrecoveryfromsevereposteriorreversibleencephalopathysyndrome AT galboisarnaud determinantsofrecoveryfromsevereposteriorreversibleencephalopathysyndrome AT chalumeaulemoineludivine determinantsofrecoveryfromsevereposteriorreversibleencephalopathysyndrome AT rivoalmichel determinantsofrecoveryfromsevereposteriorreversibleencephalopathysyndrome AT durandfrancois determinantsofrecoveryfromsevereposteriorreversibleencephalopathysyndrome AT geffroyarnaud determinantsofrecoveryfromsevereposteriorreversibleencephalopathysyndrome AT simonmarc determinantsofrecoveryfromsevereposteriorreversibleencephalopathysyndrome AT stoclinannabelle determinantsofrecoveryfromsevereposteriorreversibleencephalopathysyndrome AT pallotjeanlouis determinantsofrecoveryfromsevereposteriorreversibleencephalopathysyndrome AT arbelotcharlotte determinantsofrecoveryfromsevereposteriorreversibleencephalopathysyndrome AT nyungamartine determinantsofrecoveryfromsevereposteriorreversibleencephalopathysyndrome AT lesieurolivier determinantsofrecoveryfromsevereposteriorreversibleencephalopathysyndrome AT trochegilles determinantsofrecoveryfromsevereposteriorreversibleencephalopathysyndrome AT bruneelfabrice determinantsofrecoveryfromsevereposteriorreversibleencephalopathysyndrome AT cordolianiyvessebastien determinantsofrecoveryfromsevereposteriorreversibleencephalopathysyndrome AT bedosjeanpierre determinantsofrecoveryfromsevereposteriorreversibleencephalopathysyndrome AT picofernando determinantsofrecoveryfromsevereposteriorreversibleencephalopathysyndrome |